Outside of Treatment in Metastatic Breast Cancer

A mother whose daughter is seven years past breast cancer treatment shares how scan anxiety and waiting shape life after cancer for survivors and families.

A review of 29 studies in more than 22,000 women 65 and older with ER-positive breast cancer found no statistically significant survival difference between hormone therapy alone and surgery first, though surgery controlled the cancer in the breast better.

The FDA approved Imfinzi plus Padcev before and after surgery for adults with muscle-invasive bladder cancer who cannot or will not receive cisplatin.

Anxiety before a scan and while waiting for results is common for people with cancer and survivors. These five steps, drawn from ASCO, the American Cancer Society and the National Cancer Institute, can make the wait easier.

For Lung Cancer Awareness Month, five numbers from federal and American Cancer Society data show how survival for people with lung cancer has changed, how it differs by stage and type, and how many people are living with the disease.

A 12-year breast cancer survivor with 16 tattoos, including radiation marks, weighs new research on tattoos and lymphoma risk and the questions it prompts.

An Ohio State hematologist discusses a new trial comparing tovorafenib plus rituximab with standard cladribine-based treatment, and what quality of life means for patients.

Adding Anktiva to BCG led to better responses than BCG alone in people with high-risk bladder cancer who had not yet received BCG, the company said.